Market Overview

H.C. Wainwright Remains Positive On Galmed Pharma As ARREST Enrollment Accelerates, Sees Possible Completion By Year End, Maintains Buy And $13 PT

Share:

Get News First. Profit Faster

upsell-button
With Benzinga Professional get unlimited access to ALL content! PLUS:
  • REALTIME NEWSFEED
  • REALTIME AUDIO NEWS
  • FULL CALENDAR SUITE
  • CHAT WITH OUR NEWS DESK

Latest Ratings for GLMD

DateFirmActionFromTo
Nov 2017Roth CapitalInitiates Coverage OnBuy
Oct 2017Seaport GlobalInitiates Coverage OnBuy
Mar 2016H.C. WainwrightAssumesBuy

View More Analyst Ratings for GLMD
View the Latest Analyst Ratings

Posted-In: Analyst Color Price Target Reiteration Analyst Ratings

 

Related Articles (GLMD)

Partner Center